Abbott Laboratories
Search results
Our approach to innovation builds on strong science combined with the drive to find solutions where the need is the greatest. Our science. If we bring a new medicine to market, it can help patients worldwide, as opposed to the 20 or so patients we might see in clinic in one day.
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
Apr 18, 2022 · AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.
It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis . It developed Skyrizi ($7.8 billion in 2023 revenues), an interleukin-23 (IL-23) inhibitor also used to treat autoimmune diseases.
AbbVie In Singapore. People. Passion. Possibilities. ®. At AbbVie, we combine advanced science, expertise and passion to solve. serious health issues and have a remarkable impact on people’s lives. We are. committed to improving health care in markets where we operate. Passionate about our work.
What We Do. Our ~29,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions.
May 7, 2024 · AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives.
AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech. Since the beginning, our mission hasn't wavered.
Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.
May 7, 2024 · Innovating to meet patient needs. We partner with patients, patient organizations, caregivers and clinicians to ensure that individual experiences, perspectives, needs and priorities are part of our clinical development process. Oncology.
